Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-25 5:16 pm Purchase | 2021-10-21 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital, LP | 1,266,884 5.180% | 1,266,884![]() (New Position) | Filing History |
| 2021-09-17 4:54 pm Purchase | 2021-09-07 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,296,452 5.300% | 1,296,452![]() (New Position) | Filing History |
| 2021-06-10 11:37 am Sale | 2021-06-09 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,011,500 4.141% | -628,778![]() (-38.33%) | Filing History |
| 2021-05-27 4:44 pm Purchase | 2021-05-24 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA Capital Management, L.P. | 1,399,489 5.700% | 613,219![]() (+77.99%) | Filing History |
| 2021-05-07 4:56 pm Purchase | 2021-04-27 | 13G | KalVista Pharmaceuticals, Inc. KALV | James E. Flynn | 1,806,037 7.430% | 1,806,037![]() (New Position) | Filing History |

